The vascular endothelial growth factor (VEGF)/VEGF receptor system and its role under physiological and pathological conditions.

By Hiroyuki Takahashi, M. Shibuya. Clinical science, 2005

988 citations recorded by the source corpus.

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

Biology of vascular endothelial growth factors (2006, background): “VEGF-A also has a neuroprotective effect on hypoxic motor neurons, and is a modifier of amyotrophic lateral sclerosis [11].”
VEGF receptor signalling ? in control of vascular function (2006, background): “In addition, proteins that are structurally related to the VEGFs exist in parapoxviru”
Vascular endothelial growth factor (VEGF) - key factor in normal and pathological angiogenesis. (2018, background): “VEGFR-2 [kinase insert domain receptor (KDR) in human; fetal liver kinase 1 (Flk-1) in mouse], the predominant receptor [8], is also a member of the tyrosine kinase receptor family, with a molecular weight of 200– 230 kDa [12].”
Vascular endothelial growth factor in eye disease. (2008, background): “Investigations in mice genetically engineered to express less than the full complement of splice variants confirm that the relative solubility of VEGF splice variants strongly affects their specific bioactivities (Takahashi and Shibuya, 2005).”